Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

The Clinical Outcomes of Lenalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: A Nationwide Registry Study of the Korean Multiple Myeloma Working Party (KMMWP)

Ho Sup Lee,Chang-Ki Min,Je-Jung Lee,Kihyun Kim,Sung-Soo Yoon,Inho Kim,Soo-Mee Bang,Jin Seok Kim,Hyeon-Seok Eom,Dok Hyun Yoon,Yoojin Lee,Ho-Jin Shin,Yong Park,Jae-Cheol Jo,Won-Sik Lee,Young Rok Do,Yeung-Chul Mun,Mark Hong Lee,Hyo Jung Kim,Sung-Hyun Kim,Min Kyoung Kim,Sung-Nam Lim,Su-Hee Cho,Seong Kyu Park,Joon-ho Lee,Jae Hoon Lee

Blood（2017）

Cited 0|Views36
No score
Abstract
Background : Lenalidomide and dexamethasone (RD) is a standard of care for relapsed/refractory multiple myeloma (RRMM), but there is limited reported data on its efficacy and safety in the real clinical practice. The purpose of this study was estimate necessity of RD chemotherapy for improving survival in RRMM in real clinical fields.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined